Tech Company Financing Transactions
Sanguine BioSciences Funding Round
On 2/22/2013, Sanguine BioSciences raised Seed funding from Heliant Ventures and Invent Ventures.
Transaction Overview
Company Name
Announced On
2/22/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Heliant Ventures (Lead Investor)
Invent Ventures (Lead Investor)
Proceeds Purpose
Sanguine plans to use the funds to scale its infrastructure to collect, process, document and store up to 1,000 blood samples a month on the West Coast.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5000 Van Nuys Blvd. 205
Sherman Oaks, CA 91423
USA
Sherman Oaks, CA 91423
USA
Phone
Website
Email Address
Overview
Our mission is to facilitate and accelerate biomarker and personalized drug discovery by acknowledging the powerful role of the patient in research. We strive to develop meaningful relationships with patients that lead to empowerment and education.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Neman
Chief Financial Officer
Ivan Ivankovich
VP - Product Management
Gerald Lee
Browse more venture capital transactions:
Prev: 2/21/2013: Drawbridge venture capital transaction
Next: 2/22/2013: Blaze Bioscience venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs